Ad
related to: zantac recall
Search results
FTSE 100: GSK loses £4.5bn in value on Zantac lawsuit concerns
Yahoo Finance UK· 2 years agoGSK lost billions in value amid litigation concerns over the heartburn drug Zantac. Photo: Drew...
Pharma Stocks GSK, Sanofi And Haleon Lose Billions As Zantac Trial Looms
Investor's Business Daily· 2 years agoPharmaceutical stocks GSK, Sanofi and Haleon have wiped out a combined $31 billion in market cap...
FDA Head Questioned on Zantac’s Hidden Cancer Risk by Top Democrat DeLauro
Bloomberg via Yahoo News· 1 year ago(Bloomberg) -- The Food and Drug Administration’s chief is facing questions from a top lawmaker...
GSK's Relief For Few Months, First Trial Claiming Zantac Caused Cancer Pushed Into Late 2023
Benzinga via Yahoo Finance· 1 year agoThe first scheduled trial expected next week, related to GSK Plc's (NYSE: GSK) Zantac associated...
PFE, GSK & Other Pharma Stocks Hit by Zantac Litigation
Zacks via Yahoo Finance· 2 years agoBig pharma stocks, such as Glaxo (GSK), Sanofi (SNY), Pfizer (PFE) and Consumer stock Haleon (HLN),...
GSK attacks ‘meritless claims’ over heartburn drug Zantac
The Independent via Yahoo News· 2 years agoGSK and its consumer spin-off brand Haleon have hit back at market speculation over heartburn drug...
GSK, Sanofi shares soar as Zantac litigation fears abate
Reuters via Yahoo Finance· 1 year agoShares of GSK and Sanofi surged on Wednesday, adding more than $20 billion in combined value in...
First it was blood pressure medication. Now FDA eyes more drugs for cancer-causing chemical.
USA TODAY via Yahoo News· 1 year agoFor people managing high blood pressure, recalls of the carcinogen-tainted drug quinapril might...
UPDATE 3-GSK, Pfizer, Sanofi fend off thousands of U.S. lawsuits over alleged Zantac cancer link
Reuters via Yahoo Finance· 1 year agoDrugmakers GSK Plc, Pfizer Inc , Sanofi SA and Boehringer Ingelheim on Tuesday were spared thousands...
One Suit Down Out Of 3,000 Zantac Related Lawsuits, Says GSK
Benzinga via Yahoo Finance· 2 years agoGSK plc’s (NYSE: GSK) first scheduled Zantac related-cancer trial has been dismissed by the...
